Global demand for emergency and critical care is increasing rapidly due to conflicts, displacement, and climate-driven disasters.

By 2030, more than 500 million people per year are expected to require urgent humanitarian assistance worldwide.
In crisis and remote environments, 35–45% of patients require immediate IV therapy, irrigation, or intensive wound management, where delays beyond the critical hour are associated with marked
increases in mortality.

This creates a fast-growing segment within the global IV solutions market, where supply reliability is critical and
increasingly fragile.